Article Versions Notes

Freiwan M, Kovács MG, Kovács ZZA, Szűcs G, Dinh H, Losonczi R, Siska A, Kriston A, Kovács F, Horváth P, et al. Investigation of the Antiremodeling Effects of Losartan, Mirabegron and Their Combination on the Development of Doxorubicin-Induced Chronic Cardiotoxicity in a Rat Model. International Journal of Molecular Sciences. 2022; 23(4):2201. https://doi.org/10.3390/ijms23042201

Freiwan, Marah, Mónika G. Kovács, Zsuzsanna Z. A. Kovács, Gergő Szűcs, Hoa Dinh, Réka Losonczi, Andrea Siska, András Kriston, Ferenc Kovács, Péter Horváth, and et al. 2022. "Investigation of the Antiremodeling Effects of Losartan, Mirabegron and Their Combination on the Development of Doxorubicin-Induced Chronic Cardiotoxicity in a Rat Model" International Journal of Molecular Sciences 23, no. 4: 2201. https://doi.org/10.3390/ijms23042201

Freiwan, M., Kovács, M. G., Kovács, Z. Z. A., Szűcs, G., Dinh, H., Losonczi, R., Siska, A., Kriston, A., Kovács, F., Horváth, P., Földesi, I., Cserni, G., Dux, L., Csont, T., & Sárközy, M. (2022). Investigation of the Antiremodeling Effects of Losartan, Mirabegron and Their Combination on the Development of Doxorubicin-Induced Chronic Cardiotoxicity in a Rat Model. International Journal of Molecular Sciences, 23(4), 2201. https://doi.org/10.3390/ijms23042201